Harry S. Truman Memorial Veterans Hospital, Columbia, MO, USA.
Department of Neurology and The Center for Translational Neuroscience, M741A Medical Science Building, School of Medicine, University of Missouri, 1 Hospital Drive, Columbia, MO, USA.
Mol Neurobiol. 2018 Sep;55(9):7132-7152. doi: 10.1007/s12035-018-0882-6. Epub 2018 Jan 30.
Parkinson's disease (PD) is a progressive neurodegenerative disease affecting over five million individuals worldwide. The exact molecular events underlying PD pathogenesis are still not clearly known. Glia maturation factor (GMF), a neuroinflammatory protein in the brain plays an important role in the pathogenesis of PD. Mitochondrial dysfunctions and oxidative stress trigger apoptosis leading to dopaminergic neuronal degeneration in PD. Peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1α or PPARGC-α) acts as a transcriptional co-regulator of mitochondrial biogenesis and energy metabolism by controlling oxidative phosphorylation, antioxidant activity, and autophagy. In this study, we found that incubation of immortalized rat dopaminergic (N27) neurons with GMF influences the expression of peroxisome PGC-1α and increases oxidative stress, mitochondrial dysfunction, and apoptotic cell death. We show that incubation with GMF reduces the expression of PGC-1α with concomitant decreases in the mitochondrial complexes. Besides, there is increased oxidative stress and depolarization of mitochondrial membrane potential (MMP) in these cells. Further, GMF reduces tyrosine hydroxylase (TH) expression and shifts Bax/Bcl-2 expression resulting in release of cytochrome-c and increased activations of effector caspase expressions. Transmission electron microscopy analyses revealed alteration in the mitochondrial architecture. Our results show that GMF acts as an important upstream regulator of PGC-1α in promoting dopaminergic neuronal death through its effect on oxidative stress-mediated apoptosis. Our current data suggest that GMF is a critical risk factor for PD and suggest that it could be explored as a potential therapeutic target to inhibit PD progression.
帕金森病(PD)是一种影响全球超过 500 万人的进行性神经退行性疾病。导致 PD 发病的确切分子事件尚不清楚。脑内神经炎症蛋白胶质细胞成熟因子(GMF)在 PD 的发病机制中起着重要作用。线粒体功能障碍和氧化应激引发细胞凋亡,导致 PD 中多巴胺能神经元变性。过氧化物酶体增殖物激活受体γ共激活因子 1α(PGC-1α 或 PPARGC-α)通过控制氧化磷酸化、抗氧化活性和自噬,作为线粒体生物发生和能量代谢的转录共调节剂。在这项研究中,我们发现 GMF 孵育永生化大鼠多巴胺能(N27)神经元会影响过氧化物酶体 PGC-1α 的表达,并增加氧化应激、线粒体功能障碍和细胞凋亡。我们表明,GMF 孵育会降低 PGC-1α 的表达,同时减少线粒体复合物的表达。此外,这些细胞中的氧化应激增加,线粒体膜电位(MMP)去极化。此外,GMF 降低酪氨酸羟化酶(TH)的表达并改变 Bax/Bcl-2 的表达,导致细胞色素 c 的释放和效应半胱天冬酶表达的增加。透射电子显微镜分析显示线粒体结构发生改变。我们的结果表明,GMF 作为 PGC-1α 的重要上游调节剂,通过其对氧化应激介导的细胞凋亡的影响,促进多巴胺能神经元死亡。我们目前的数据表明 GMF 是 PD 的一个关键危险因素,并表明它可以作为抑制 PD 进展的潜在治疗靶点进行探索。